NOVO NORDISK INC. for NOVO NORDISK INC.
What was lobbied
8 issue areas, each in the filer's own words, with who lobbied on it and where.
Veterans VET
Issues related to insulin pen safety and access in the VA
| Lobbyist | Covered position, as disclosed |
|---|---|
| TRICIA BROOKS | — |
| CHRISTOPHER MCGOWEN | — |
| SARAH ELIZABETH NORDSTROM | — |
| CHRISTOPHER PORTER | — |
| LAUREN ELIZABETH SEMENIUK | — |
| AMY CATHERINE THIENEL | — |
Health Issues HCR
National Diabetes Prevention Program; Better care and treatment of people with diabetes under P.L. 111-148 Patient Protection and Affordable Care Act of 2009 (ACA) and P.L. 111-152 The Health Care & Education Affordability Reconciliation Act of 2010: Issues related to diabetes generally, and specifically diabetes screening, medical education and death certificate reporting (Catalyst for Better Diabetes), Prevention and Public Health Fund, AHRQ and USPSTF diabetes screening standards;Diabetes issues in Healthy People 2020 and the Office of Disease Prevention and Health Promotion (ODPHP); H.R. 1074 and S. 539 National Diabetes Clinical Care Commission Act of 2013; S.RES.242 and H.RES.313 Supporting the goals and ideals of "Growth Awareness Week" and the MAGIC Foundation; H.R. 8 American Taxpayer Relief Act (Special Diabetes Program reauthorization); H.R. 1915 and S. 907 Gestational Diabetes Act of 2013; H.R. 3322 Eliminating Disparities in Diabetes Prevention, Access, and Care Act of 2013; H.R. 351 and S. 351 Protecting Seniors' Access to Medicare Act of 2013 (IPAB repeal)
| Lobbyist | Covered position, as disclosed |
|---|---|
| TRICIA BROOKS | — |
| CHRISTOPHER MCGOWEN | — |
| SARAH ELIZABETH NORDSTROM | — |
| CHRISTOPHER PORTER | — |
| LAUREN ELIZABETH SEMENIUK | — |
| AMY CATHERINE THIENEL | — |
Medicare/Medicaid MMM
H.R. 962 and S. 452 Medicare Diabetes Prevention Act of 2013; Issues related to Medicare Part D and Medicaid rebates as contained in P.L. 112-25 Budget Control Act of 2011, H.R. 8 American Taxpayer Relief Act of 2012, and H.R. 1588 and S. 740 Medicare Drug Savings Act of 2013; H.R. 1257 Preventing Diabetes in Medicare Act of 2013 and prediabetes generally; H.R. 1274 and S. 945 Access to Quality Diabetes Education Act of 2013 (Diabetes Self-Management Training in Medicare);Medicare diabetes screening generally; S. 1184 and H.R. 2415 Treat and Reduce Obesity Act of 2013; Diabesity amendment to S. 1871 SGR Repeal and Medicare Beneficiary Access; Physician Quality and Reporting System (PQRS)
| Lobbyist | Covered position, as disclosed |
|---|---|
| TRICIA BROOKS | — |
| CHRISTOPHER MCGOWEN | — |
| SARAH ELIZABETH NORDSTROM | — |
| CHRISTOPHER PORTER | — |
| LAUREN ELIZABETH SEMENIUK | — |
| AMY CATHERINE THIENEL | — |
Budget/Appropriations BUD
Issues related to Medicare Part D, FDA & patents in S. Con. Res. 8 FY14 Senate Budget Resolution; H. Con. Res. 25 House Budget Resolution; H.R. 2663 & S. 1422 The Preventative Health Savings Act of 2013 (Modernizing CBO scoring estimates with respect to preventive health legislation); National Diabetes Prevention Program in H.R. 933 FY13 Consolidated and Further Continuing Appropriations Act & S. 1284 FY14 Depts. of Labor, Health and Human Services, and Education Appropriations ActH.J. Res 59 FY14 Continuing Appropriations Resolution (contains Bipartisan Budget Act of 2013) and issues related to the continuing resolution and debt ceiling.
| Lobbyist | Covered position, as disclosed |
|---|---|
| TRICIA BROOKS | — |
| CHRISTOPHER MCGOWEN | — |
| SARAH ELIZABETH NORDSTROM | — |
| CHRISTOPHER PORTER | — |
| LAUREN ELIZABETH SEMENIUK | — |
| AMY CATHERINE THIENEL | — |
Pharmacy PHA
P.L. 113-054 Drug Quality and Security Act, H.R.1919 Safeguarding America's Pharmaceuticals Act of 2013 and S.959 Pharmaceutical Compounding Quality and Accountability Act (for track and trace supply chain provisions); issues regarding biosimilars; 340B
| Lobbyist | Covered position, as disclosed |
|---|---|
| TRICIA BROOKS | — |
| CHRISTOPHER MCGOWEN | — |
| SARAH ELIZABETH NORDSTROM | — |
| CHRISTOPHER PORTER | — |
| LAUREN ELIZABETH SEMENIUK | — |
| AMY CATHERINE THIENEL | — |
Taxation/Internal Revenue Code TAX
H.R. 8 American Taxpayer Relief Act (R&D tax credit) of 2012 (R&D credit); H.R. 2052 and S. 1023 Global Investment in American Jobs Act
| Lobbyist | Covered position, as disclosed |
|---|---|
| TRICIA BROOKS | — |
| CHRISTOPHER MCGOWEN | — |
| SARAH ELIZABETH NORDSTROM | — |
| CHRISTOPHER PORTER | — |
| LAUREN ELIZABETH SEMENIUK | — |
| AMY CATHERINE THIENEL | — |
Trade (domestic/foreign) TRD
EU/US Transatlantic Trade and Investment Partnership (TTIP) (intellectual property); Trans-Pacific Partnership (TPP) (intellectual property)
| Lobbyist | Covered position, as disclosed |
|---|---|
| TRICIA BROOKS | — |
| CHRISTOPHER MCGOWEN | — |
| SARAH ELIZABETH NORDSTROM | — |
| CHRISTOPHER PORTER | — |
| LAUREN ELIZABETH SEMENIUK | — |
| AMY CATHERINE THIENEL | — |
Copyright/Patent/Trademark CPT
H.R. 3309 Innovation Act and S. 1720 Patent Transparency and Improvements Act of 2013 (patent litigation and patent assertion)
| Lobbyist | Covered position, as disclosed |
|---|---|
| TRICIA BROOKS | — |
| CHRISTOPHER MCGOWEN | — |
| SARAH ELIZABETH NORDSTROM | — |
| CHRISTOPHER PORTER | — |
| LAUREN ELIZABETH SEMENIUK | — |
| AMY CATHERINE THIENEL | — |
Foreign entities
Foreign owners and affiliates the filer disclosed. Amounts are as declared on this filing.
| Entity | Country | Principal place of business | Ownership | Contribution declared |
|---|---|---|---|---|
| NOVO A/S | Denmark | Denmark | 25.5% | — |
| NOVO NORDISK A/S | Denmark | Denmark | 100.0% | — |
| NOVO NORDISK FONDEN (FOUNDATION) | Denmark | Denmark | 25.5% | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.